Single Ascending and Multiple Ascending Dose Study of LCA-0061
Abroad (travel likely)RecruitingPHASE1
Conditions
Atopic Disease · Peanut Allergies
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CAN001, Mississauga, Ontario, Canada
Contact: Study coordinator (Principal Investigator) · LCA-0061studyinquiry@lyciatx.com · 650-392-3357
Study leads
Nadia Tchao, MD
Study Director
Lycia Therapeutics, Inc.